SE

Suchitra Holgersson

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suchitra Holgersson. Retrieved from https://idiyas.com/inventor/suchitra-holgersson-nwiazpnh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Suchitra Holgersson: Innovator in Hepatic Progenitor Cell Research

Introduction

Suchitra Holgersson is a prominent inventor based in Sweden, recognized for her contributions to the field of regenerative medicine. She has focused her research on human hepatic progenitor cells, which hold significant potential for liver-related therapies. Her innovative work aims to advance the understanding and application of these cells in medical treatments.

Latest Patents

Suchitra Holgersson holds a patent titled "Human Hepatic Progenitor Cells And Methods Of Use Thereof." This patent describes liver progenitor cells that are immunoreactive for CD117 and CD34. These cells are capable of proliferating in culture and can differentiate in vivo into hepatocytes, cholangiocytes, or sinusoidal cells. The cultures can be expanded over a large number of passages and integrate well after transplantation into the adult liver. Despite her groundbreaking work, she currently has 0 patents.

Career Highlights

Holgersson has made significant strides in her career, particularly through her association with Nov Ahep AB. Her research has contributed to the understanding of liver cell biology and the potential for regenerative therapies. Her work is vital in addressing liver diseases and improving patient outcomes.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Suchitra Holgersson is a key figure in the field of hepatic progenitor cell research, with her innovative work paving the way for future advancements in liver therapies. Her contributions are essential for the ongoing development of regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…